ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Texas gives green-light for experimental stem-cell therapies – LifeNews.com

Continue reading

2017-06-26 Michael Zand NEWS

What’s Hot in Cancer Immunotherapy 2017: The Photos – Xconomy


LifeNews.com

Texas gives green-light for experimental stem–cell therapies
LifeNews.com
Last week Governor Greg Abbott signed off on the new legislation that allows clinics to by-pass FDA approval for investigational stem cell treatments for patients with certain severe chronic diseases or terminal illnesses. Like “right to try” laws in …

Continue reading

2017-06-26 Michael Zand NEWS

Can CRISPR Tackle Zika? – Contagionlive.com

Can CRISPR Tackle Zika?Contagionlive.comCRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a relatively new biotechnology that allows the user to target specific genetic codes within DNA and edit them, working like a pair of DNA scis… Continue reading

2017-06-26 Michael Zand NEWS

Huntington’s disease in mice partly reversed using CRISPR – BioNews


Xconomy

What’s Hot in Cancer Immunotherapy 2017: The Photos
Xconomy
Xconomy’s cancer immunotherapy event on June 14th in Seattle brought a packed house to The Pelton Auditorium on the campus of the Fred Hutchinson Cancer Research Center. Attendees heard top executives, physicians, researchers, investors and …
Cancer Research Institute Awards $1 Million to Fund the Development of Innovative Microchip-Based Research …Newswise (press release)

all 2 news articles »

Continue reading

2017-06-26 Michael Zand NEWS

Immunotherapy Brings New Hope to Patients with Advanced Melanoma – Newswise (press release)

Immunotherapy Brings New Hope to Patients with Advanced MelanomaNewswise (press release)After having surgery to repair the damage from the tumors in her ankle, her doctors encouraged her to enroll in a clinical trial of immunotherapy for patients with … Continue reading

2017-06-26 Michael Zand NEWS

Immunotherapy Brings New Hope to Patients with Advanced Melanoma – Newswise (press release)

Immunotherapy Brings New Hope to Patients with Advanced MelanomaNewswise (press release)After having surgery to repair the damage from the tumors in her ankle, her doctors encouraged her to enroll in a clinical trial of immunotherapy for patients with … Continue reading

2017-06-26 Michael Zand NEWS

BRIEF-Theraclion announces FDA authorization to start US trial for immunotherapy and echotherapy combination on … – Reuters

BRIEF-Theraclion announces FDA authorization to start US trial for immunotherapy and echotherapy combination on …ReutersSAO PAULO, June 26 The Brazilian unit of U.S. food processor Cargill agreed to sell a fruit processing plant located in the Sao Pa… Continue reading

2017-06-26 Michael Zand NEWS

Theraclion Announces FDA Authorization to Start US Trial for Immunotherapy and Echotherapy Combination on Breast … – Business Wire (press release)

Huntington’s disease in mice partly reversed using CRISPR
BioNews
Eliminating the faulty protein that causes Huntington’s disease goes some way to reversing disease progression in mice, a study has found. Scientists used the genome editing technique CRISPR/Cas9 to ‘switch off’ the disease-causing gene in mice brains, …

Continue reading

2017-06-26 Michael Zand NEWS
  • 1
  • …
  • 1,575
  • 1,576
  • 1,577
  • 1,578
  • 1,579
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Theraclion Announces FDA Authorization to Start US Trial for Immunotherapy and Echotherapy Combination on Breast …
Business Wire (press release)
Immunotherapy stimulates the body’s own immune system to fight tumor cells. HIFU, which has already demonstrated its efficacy in the treatment of malignant and benign tumors, could have a major impact on the efficacy of immunotherapy when delivered as …